Signaling and Ligand Binding by Recombinant Neuromedin U Receptors: Evidence for Dual Coupling to Gαq/11 and Gαi and an Irreversible Ligand-Receptor Interaction
- 1 December 2004
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 66 (6) , 1544-1556
- https://doi.org/10.1124/mol.104.002337
Abstract
The neuropeptide neuromedin U (NmU) shows considerable structural conservation across species. Within the body, it is widely distributed and in mammals has been implicated in physiological roles, including the regulation of feeding, anxiety, pain, blood flow, and smooth muscle contraction. Human NmU-25 (hNmU-25) and other NmU analogs were recently identified as ligands for two human orphan G protein-coupled receptors, subsequently named hNmU-R1 and hNmU-R2. These receptors have approximately 50% amino acid homology, and, at least in mammalian species, NmU-R1 and NmU-R2 are expressed predominantly in the periphery and central nervous system, respectively. Here, we have characterized signaling mediated by hNmU-R1 and hNmU-R2 expressed as recombinant proteins in human embryonic kidney 293 cells, particularly to define their G protein coupling and the activation and regulation of signal transduction pathways. We show that these receptors couple to both Gαq/11 and Gαi. Activation of either receptor type causes a pertussis toxin-insensitive activation of both phospholipase C and mitogen activated-protein kinase and a pertussis toxin-sensitive inhibition of adenylyl cyclase with subnanomolar potency for each. Activation of phospholipase C is sustained, but despite this capacity for prolonged receptor activation, repetitive application of hNmU-25 does not cause repetitive intracellular Ca2+ signaling by either recombinant receptors or those expressed endogenously in isolated smooth muscle cells from rat fundus. Using several strategies, we show this to be a consequence of essentially irreversible binding of hNmU-25 to its receptors and that this is followed by ligand internalization. Despite structural differences between receptors, there were no apparent differences in their activation, coupling, or regulation.Keywords
This publication has 38 references indexed in Scilit:
- Neuromedin U and Its Receptors: Structure, Function, and Physiological RolesPharmacological Reviews, 2004
- Cardiovascular actions of central neuromedin U in conscious ratsRegulatory Peptides, 2002
- Diversity of G Protein-Coupled Receptor Signaling Pathways to ERK/MAP KinaseNeurosignals, 2002
- Homologous and heterologous uncoupling of muscarinic M3 and α1B adrenoceptors to Gαq/11 in SH‐SY5Y human neuroblastoma cellsBritish Journal of Pharmacology, 2001
- Gq/11 and Gi/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor‐subtypeBritish Journal of Pharmacology, 2001
- Activation of the Mitogen-activated Protein Kinase Pathway by a Gq/11-coupled Muscarinic Receptor Is Independent of Receptor InternalizationPublished by Elsevier ,1999
- Human AT1 receptor is a single copy gene: Characterization in a stable cell lineMolecular and Cellular Biochemistry, 1994
- Evidence that neuromedin U may regulate gut motility in reptiles but not in mammalsEuropean Journal of Pharmacology, 1989
- Distribution and characterisation of neuromedin U-like immunoreactivity in rat brain and intestine and in guinea pig intestineRegulatory Peptides, 1988
- A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphateBiochemical Journal, 1971